The global assisted reproductive technology (ART) market was valued at USD 21.32 billion in 2018 and is expected to reach USD 45.06 billion by 2026, growing at a compound annual growth rate (CAGR) of 9.8% during the forecast period. Europe emerged as the leading region, accounting for 41.18% of the global market share in 2018.
Assisted reproductive technologies, often referred to as assisted reproductive treatments, encompass various advanced techniques designed to address infertility. These procedures span a wide range of solutions tailored to the specific causes of infertility, offering personalized approaches to improving reproductive outcomes.
Read More :Â https://www.fortunebusinessinsights.com/industry-reports/assisted-reproductive-technology-art-market-101811
Key Industry Development
In August 2018, GI Partners acquired California Cryobank (CCB) and Cord Blood Registry (CBR) to establish a stronghold in the stem cell storage and reproductive tissue services markets. This acquisition highlights the growing importance of advanced reproductive technologies and storage services in addressing infertility challenges worldwide.
Top Companies in the Assisted Reproductive Technology Market
- Bloom IVF Centre
- California Cryobank
- CARE Fertility
- Monash IVF Group
- Carolinas Fertility Institute
- European Sperm Bank
- INVO Bioscience
- Apollo Hospitals Enterprise Ltd.
Market Drivers & Restraints
The growth of the global assisted reproductive technology (ART) market is primarily driven by the increasing prevalence of infertility worldwide. Lifestyle changes, delayed pregnancies, and rising awareness about fertility treatments have led to a surge in demand for ART services. Additionally, advancements in technology, such as in-vitro fertilization (IVF) and cryopreservation, are enhancing treatment success rates.
However, the market faces challenges such as high treatment costs and ethical concerns surrounding assisted reproductive procedures. Limited insurance coverage for fertility treatments also acts as a restraint in many regions, particularly in low- and middle-income countries.
Market Report Coverage
The market report on assisted reproductive technology provides a comprehensive analysis of industry trends, including emerging technologies, regulatory frameworks, and success rates of various ART procedures. It also offers a detailed overview of market segmentation, competitive strategies, and regional insights.
Market Competitive Landscape
The competitive landscape of the ART market is marked by the presence of key players focusing on innovation and strategic partnerships. Companies are leveraging advancements in cryopreservation, embryology, and artificial intelligence to improve patient outcomes. The acquisition of California Cryobank by GI Partners serves as a prime example of industry consolidation aimed at expanding service portfolios and geographic reach.
Market Segments
The ART market is segmented into various treatment options, including in-vitro fertilization (IVF), intrauterine insemination (IUI), and cryopreservation. Among these, IVF is the leading segment, driven by its high success rates and widespread adoption across fertility clinics. The cryopreservation segment is also witnessing rapid growth, owing to its role in preserving eggs, sperm, and embryos for future use.
Market Regional Insights
North America dominates the ART market, owing to the high prevalence of infertility and the availability of advanced healthcare infrastructure. Europe follows closely, supported by favorable regulatory policies and increasing acceptance of ART procedures. Meanwhile, the Asia-Pacific region is expected to witness the fastest growth, driven by rising awareness, increasing disposable income, and the establishment of fertility clinics in countries like India and China.
Future Market Scope
The future of the assisted reproductive technology market looks promising, with significant advancements on the horizon. Innovations in genetic testing, artificial intelligence, and embryo selection techniques are expected to improve the success rates of fertility treatments. Additionally, increasing investments in research and development will drive the introduction of new and cost-effective ART procedures, making treatments more accessible to a larger population.
Furthermore, as societal attitudes toward ART continue to evolve, the market is likely to witness greater acceptance of these technologies, paving the way for sustained growth in the coming years.
